ClinicalTrials.Veeva

Menu

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !?

A

Al Baraka Fertility Hospital

Status

Unknown

Conditions

IVF

Study type

Observational

Funder types

Other

Identifiers

NCT04265495
AlBarakaBH-KAMAL

Details and patient eligibility

About

a comparative study among dual trigger, urinary HCG and recombinant HCG regarding the outcome of ICSI- antagonist cycles

Full description

a comparative study among dual trigger, urinary HCG and recombinant HCG regarding the outcome (oocyte quality, fertilization rate, implantation rate, clinical pregnancy rate as well as the incidence of OHSS) in ICSI- antagonist cycles

Enrollment

600 estimated patients

Sex

Female

Ages

22 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients <40 years of age who underwent IVF/ICSI cycles using a GnRH antagonist protocol

Exclusion criteria

  • age: > 40 years
  • BMI > 30 ,
  • long agonist protocol
  • were chromosomal and genetic disorders, abnormal ultrasonogram of the uterine cavity

Trial design

600 participants in 3 patient groups

DUAL TRIGGERING
Description:
PATIENTS WILL RECEIVE DUAL TRIGGERING
URINARY HCG
Description:
PATIENTS WILL RECEIVE URINARY HCG
RECOMBINANT HCG
Description:
PATIENTS WILL RECEIVE RECOMBINANT HCG

Trial contacts and locations

1

Loading...

Central trial contact

Kamal eldin Rageh, M.D.; Ahmed Barakat, FRCOG

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems